InvestorsHub Logo
icon url

mide

07/29/11 4:09 PM

#130741 RE: bankinonit #130740

So do I on first blush...have witnessed first hand 5 reverses orchestrated by them in Genta and 3 in CellTech both biotechs.

However, having said that, those occurred primarily in the absence of an approved product for market by the FDA.

If WSGI can get a DOD certified product and gain contracts and net profitable revenues, the advantage of a Rodman becomes an asset potentially.

However, once they have their teeth in this with any appreciable leverage, and some sort of glitch occurs and funds have to be raised at low prices...a reverse will likely happen based on their prior historical motives in those scenarios.

My question which was not answered at the SHM as I nor anyone asked..

Why do we need 8-9mm dollars right now if we have contracts coming?

For what purpose?

After all with 1.5 mm on hand and 1.5mm in the wings from Space Florida and revenues coming in from GTC, why?

m